Cardinal Health, Inc. (NYSE:CAH – Free Report) – Stock analysts at Leerink Partnrs cut their Q3 2025 earnings per share estimates for shares of Cardinal Health in a research report issued to clients and investors on Monday, March 31st. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings of $2.16 per share for the quarter, down from their prior estimate of $2.18. The consensus estimate for Cardinal Health’s current full-year earnings is $7.95 per share. Leerink Partnrs also issued estimates for Cardinal Health’s FY2027 earnings at $9.90 EPS and FY2028 earnings at $10.84 EPS.
Cardinal Health (NYSE:CAH – Get Free Report) last announced its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%.
Check Out Our Latest Analysis on CAH
Cardinal Health Price Performance
Shares of NYSE:CAH opened at $138.82 on Thursday. Cardinal Health has a 12 month low of $93.17 and a 12 month high of $139.15. The stock’s 50 day moving average price is $128.98 and its 200 day moving average price is $121.33. The stock has a market cap of $33.53 billion, a price-to-earnings ratio of 25.90, a PEG ratio of 1.49 and a beta of 0.66.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the business. Norges Bank acquired a new stake in shares of Cardinal Health in the fourth quarter worth $246,748,000. Marshall Wace LLP increased its holdings in shares of Cardinal Health by 154.6% during the 4th quarter. Marshall Wace LLP now owns 3,151,736 shares of the company’s stock worth $372,756,000 after purchasing an additional 1,913,892 shares during the period. Castlekeep Investment Advisors LLC acquired a new position in shares of Cardinal Health during the fourth quarter valued at about $141,963,000. Junto Capital Management LP bought a new stake in shares of Cardinal Health in the fourth quarter valued at about $92,811,000. Finally, Woodline Partners LP acquired a new stake in Cardinal Health during the fourth quarter worth about $87,144,000. 87.17% of the stock is owned by institutional investors.
Cardinal Health Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a yield of 1.46%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s dividend payout ratio (DPR) is currently 37.69%.
Cardinal Health Company Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also
- Five stocks we like better than Cardinal Health
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Tesla Stock: What To Expect With Their Delivery Numbers Report
- Earnings Per Share Calculator: How to Calculate EPS
- First Watch Restaurant Group: A First-Rate Small-Cap Growth Stock
- Manufacturing Stocks Investing
- Rocket Lab: $5.6 Billion Defense Contract Fuels RKLB’s Future
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.